Enteroendocrine tumors other than carcinoid: A review of clinically significant advances

Keyphrases

• Clinically Significant 100%
• Tumor 100%
• Carcinoid 100%
• Enteroendocrine 100%
• Cancer Patients 50%
• Excision 50%
• Self-help 50%
• Clinical Course 50%
• Growth Rate 50%
• Cytoreductive Surgery 50%
• Neuroendocrine Tumor 50%
• Tumor-specific 50%
• Combined Modality Therapy 50%
• Zollinger-Ellison Syndrome 50%
• Hypokalemia 50%
• Hypoglycemia 50%
• Clinical Characterization 50%
• Palliation 50%
• Clinical Recognition 50%
• Achlorhydria 50%
• Heterogenous Groups 50%
• Insulinoma 50%
• Patient Support 50%
• Gut Hormones 50%
• Biological Behavior 50%
• Malignant Cancer 50%
• Malignancy Grade 50%
• Endocrine Function 50%
• Watery Diarrhea 50%
• Product-specific 50%
• Somatostatin Analogs 50%
• Endocrine Syndrome 50%
• Glucagonoma 50%
• Gastrinoma 50%
• Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) 50%
• Glucagonoma Syndrome 50%
• Enactive Approach 50%

Medicine and Dentistry

• Carcinoid 100%
• Neuroendocrine Tumor 100%
• Tumor 100%
• Glucagonoma 100%
• Cancer 50%
• Disease Course 50%
• Diarrhea 50%
• Specific Tumor 50%
• Endocrine Disease 50%
• Symptomatic Treatment 50%
• Zollinger-Ellison Syndrome 50%
• Hypokalemia 50%
• Hypoglycemia 50%
• Nesidioblastosis 50%
• Gastrointestinal Hormone 50%
• Endocrine Function 50%
• Somatostatin Derivative 50%
• Patient Support Group 50%
• Gastrinoma 50%
• Achlorhydria 50%